News & Updates
Filter by Specialty:
Pimavanserin for dementia-related psychosis: to continue or not?
01 Oct 2021
byAudrey Abella
In individuals with dementia-related psychosis (DRP) who had a response to the oral 5-HT2A* inverse agonist and antagonist pimavanserin, an atypical antipsychotic agent, the risk of relapse was lower among those who continued the drug vs those who stopped it, the phase III HARMONY trial suggests.
Pimavanserin for dementia-related psychosis: to continue or not?
01 Oct 2021High cEPC counts tied to worse anxiety, depression in MDD patients
28 Sep 2021
Elevated counts of circulating endothelial progenitor cells (cEPCs) are correlated to worse anxiety, more severe depressive symptoms, poorer cognitive performance, greater social disability, and impaired overall mental health in patients with major depressive disorder (MDD), a recent study has found.